August 9, 2023 Experience Recursion Pharmaceuticals $300 million at-the-market offering The shares are listed on the Nasdaq Global Select Market
August 9, 2023 Experience MicroStrategy $750 million at-the-market offering The stock is listed on the Nasdaq Global Select Market
August 8, 2023 Experience Hayward Holdings $317 million secondary offering The stock is listed on the New York Stock Exchange
August 8, 2023 Experience NGM Biopharmaceuticals $100 million at-the-market offering The shares are listed on the Nasdaq Global Select Market
July 28, 2023 Experience BMS $35 million investment in Immatics We advised Immatics on the private placement of ordinary shares
July 5, 2023 Experience NKT DKK 2.7 billion rights offering The new shares are listed on Nasdaq Copenhagen
July 5, 2023 Experience Nextracker $662.5 million common stock offering We advised Nextracker on the SEC-registered secondary offering
June 27, 2023 Experience IDEAYA Biosciences $250 million at-the-market offering The shares are listed on the Nasdaq Global Select Market
June 26, 2023 Experience AB Sagax SEK$2.06 billion equity offering We advised AB Sagax on the offering of shares via an accelerated book-building process
June 20, 2023 Experience Editas Medicine $125 million follow-on offering The stock is listed on the Nasdaq Global Select Market